GENE ONLINE|News &
Opinion
Blog

Depression
Psychedelics and Health PsilocybinDepression
Cybin’s Breakthrough: Psychedelic Depression Drug CYB003 Sustains 12-Month Symptom Remission in Major Depressive Disorder
2024-11-19
R&D DepressionGenetics
A New Study has Linked Treatment Resistant Depression to Body Mass Index
2024-05-16
Technology Brain-Computer InterfaceNeuroscience
Rice University Engineers Develop Miniature Brain Stimulator for Safer and Less-invasive Neuromodulation
2024-04-17
R&D DepressionChatGPT
ChatGPT’s Impact on Depression Management: A Game Changer in Mental Health
2023-10-25
Technology Depression
Abbott’s Looks to Treat Depression With Breakthrough Device Status
2022-07-13
Special 2022 psychedelics
Refining Psychedelics into Medicine – An Interview with Doug Drysdale, CEO of Cybin
2022-04-19
Interviews 2022 psychedelics
The Renaissance of Psychedelics Research: An Interview with the CEO of MindMed, Rob Barrow
2022-04-12
Biotech Marijuana
Marijuana for Medical Use Increases the Risk of Cannabis Use Disorder
2022-03-25
Feature 2022 psychedelics
History on Depression Therapy: the Past and the Psychedelic Future
2022-03-21
Special 2022 psychedelics
From Forbidden Drugs to Psychotropic Cures: A “Psychedelic Boom” Breaks New Ground in Treating Mental Illnesses
2022-03-08
M&A Neuroscience
Abbvie Acquires Neuroscience Company Syndesi for $1 Billion
2022-03-02
Funding Digital HealthcareSeries C Funding
Mental Healthcare Startup Cerebral Valued at $4.8 Billion after $300 Million Softbank-led Series C
2021-12-10
R&D Depression
Biogen and Sage Therapeutics Ink Deal for Treating Depression
2020-11-29
Trials & Approvals Depression
VistaGen’s Antidepressant Nasal Spray Succeeds Phase 2a Trial
2020-02-22
In-Depth Depression
SECUADO – The Hope to Enhance Schizophrenia Patients’ Quality of Life
2019-11-14
1 2
LATEST
Neuro, Pain, and Cancer Top the List at JPM 2025 Healthcare Conference
2025-01-17
ZYN Nicotine Pouches Receive FDA Marketing Authorization
2025-01-17
Virginia’s Insurance Marketplace Extends Open Enrollment Deadline: A Detailed Report
2025-01-16
2025 Starts with a Jolt: Layoffs Hit the Life Sciences Industry Ahead of JPM
2025-01-16
Eli Lilly Steals the Spotlight at JPM 2025 with $2.5 Billion Power Move Acquisition
2025-01-16
Pre-JPM 2025: The Quiet Deals You May Have Missed Before the Big Show
2025-01-16
JPM 2025’s Billion Dollar Deal – GSK Bids Big in GI Cancer
2025-01-15
READ MORE
EVENT
2025-02-05
Precision Medicine World Conference 2025
Santa Clara, California
2025-02-19
Healthcare Conference Taipei 2025
Taipei, Taiwan
2025-03-17
BIO-Europe Spring 2025
Milan, Italy
2025-04-02
Asia Cell and Gene Therapy Innovation Summit 2025
Shanghai, China
2025-04-21
World Vaccine Congress 2025
Washington, U.S.A
2025-04-25
AACR Annual Meeting 2025
Chicago, U.S.A
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2025 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top